Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Microbiotia Ltd.. (5/9/17). "Press Release: Microbiotica Appoints John Shields as Non-Executive Director".

Organisations Organisation Microbiotica Ltd.
  Organisation 2 Sanger Institute, The Wellcome Trust
  Group Wellcome Trust, The
Products Product microbiomics
  Product 2 microbiomic treatment (live biotherapeutics)
Persons Person Shields, John (Sanger Institute + Crick + MRC before Abingworth Management + Cantab Pharmaceuticals + GSK)
  Person 2 Romanos, Mike (Microbiotica 201612– CEO before Crescendo Biologics CEO before CSO since 5/09 before GSK)
     


Microbiotica, the spin-out company from the UK’s Wellcome Trust Sanger Institute (Sanger Institute), is pleased to announce the appointment of Dr John Shields as a non-executive director representing the Sanger Institute.

Dr Shields has extensive operational and investment experience in the biotechnology sector and is currently a member of the Sanger Institute Translation Committee, the Crick Institute Translation Advisory Group and the Medical Research Council’s Translational Research Group. He serves on a number of biotechnology company boards and is an adviser to several venture capital groups. Previously, he was an adviser to Abingworth Management, the life-sciences focused venture capital group, and has also worked in the pharma and biotech industry, initially at Glaxo and then as SVP Research for Cantab Pharmaceuticals.

Mike Romanos, Chief Executive Officer of Microbiotica, commented: “We are delighted to welcome John to Microbiotica’s Board. His experience in the translation of innovative science will bring invaluable insights to the company as we work to commercialise ground-breaking research into the role of the human microbiome in health and disease, and its application to medicine. His appointment is a welcome and tangible demonstration of our ongoing close link with the Sanger Institute, and I am sure he will make an immediate and important contribution to the team.”

Dr Shields commented: “Microbiotica is an immensely interesting organisation with, I believe, significant potential to apply its understanding of the role of human gut microbiome in health and disease to develop bacteriotherapies. I am looking forward to helping the team realise the enormous opportunity which is emerging from our increased knowledge of the role of the microbiome and to offering a new approach for treating diseases for which conventional treatments have been inadequate.”

Dr Shields joins existing Microbiotica Board members Mike Romanos, CEO, and Trevor Lawley, Chief Scientific Officer, along with Sam Williams, Head of Biotech at IP Group plc, and Robert Tansley, Investment Director at Cambridge Innovation Capital plc.


- ENDS -


Notes about Microbiotica

> Microbiotica was established in 2016 to develop and commercialise ground-breaking research into the role of the human microbiome in health and disease and its application to medicine conducted in the Host-Microbiotica Interactions Laboratory (“HMIL”) at the Sanger Institute.

> Microbiotica’s founders are Mike Romanos, Trevor Lawley and Gordon Dougan, FRS.

> CIC and IP Group are co-investors in Microbiotica, with a £4m contribution from each party to provide total initial funding of £8m.

> Microbiotica is based at the Wellcome Genome Campus in Cambridge, UK, with offices in the Biodata Innovation Centre and laboratories in the Sanger Institute.

   
Record changed: 2017-11-29

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Microbiotica Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px